Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Jungyeon Hwang"'
Publikováno v:
Micro and Nano Systems Letters, Vol 6, Iss 1, Pp 1-7 (2018)
Abstract In this research, we present the feasibility testing results of a simple distance measurement system using microfabricated scanning micromirrors. Two different configurations have been tested with different types of micromirrors. In the firs
Externí odkaz:
https://doaj.org/article/eb771532ef534bdea87d8f2e2619a797
Publikováno v:
International Journal of Nanomedicine, Vol 2008, Iss Issue 3, Pp 359-371 (2008)
Jungyeon Hwang1, Kathleen Rodgers2, James C Oliver3, Thomas Schluep11Insert Therapeutics, Inc., Pasadena, CA, USA; 2Livingston Research Institute, Los Angeles, CA, USA; James C Oliver, Peptagen, Inc., Raleigh, NC USAAbstract: A glycinate derivative o
Externí odkaz:
https://doaj.org/article/25cabd130b424973a99846497d2ca988
Publikováno v:
IEEE Wireless Communications Letters. 11:898-902
Autor:
Nikolai Rakhilin, Bing Yang, Mary E. Spilker, Lisa K. Manzuk, Mary Katherine Montgomery, Eyoung Shin, Nadira Prashad, Jungyeon Hwang, Youngho Song, Frank Loganzo, Anand Giddabasappa, Sripad Ram
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society.
Nanoparticle (NP) technology holds significant promise to mediate targeted drug delivery to specific organs in the body. Understanding the 3D biodistribution of NPs in heterogeneous environments such as the tumor tissue can provide crucial informatio
Autor:
Geeti Gangal, Sonke Svenson, Chester A. Metcalf, Pochi Shum, Snehlata Tripathi, Jungyeon Hwang, Stephanie Harlfinger, Beata Sweryda-Krawiec, Roy I. Case, Douglas Lazarus, Derek van der Poll, Sujan Kabir, Donna Brown, Ellen Rohde, Chi-Hse Teng, Roderic O. Cole, Scott Eliasof
Publikováno v:
Journal of Medicinal Chemistry. 62:9541-9559
Novel nanoparticle-drug conjugates (NDCs) containing diverse, clinically relevant anticancer drug payloads (docetaxel, cabazitaxel, and gemcitabine) were successfully generated and tested in drug discovery studies. The NDCs utilized structurally vari
Publikováno v:
Electrochimica Acta. 252:482-489
Titanium dioxide is an important metal-oxide semiconductor for photocatalytic applications owing to its unique properties, such as photostability, abundance, low cost, and nontoxicity. However, the photocatalytic activity of TiO2 is limited due to it
Autor:
Pei-Sze Ng, Patrick Lim Soo, Sonke Svenson, Snehlata Tripathi, Roy I. Case, Sujan Kabir, Douglas Lazarus, Pochi Shum, Roderick O. Cole, Derek van der Poll, Jungyeon Hwang, Scott Eliasof, Beata Sweryda-Krawiec, Christian G. Peters
Publikováno v:
Molecular Pharmaceutics. 13:737-747
Small interfering RNA (siRNA) therapeutics have potential advantages over traditional small molecule drugs such as high specificity and the ability to inhibit otherwise "undruggable" targets. However, siRNAs have short plasma half-lives in vivo, can
Autor:
Christian G. Peters, Joseph Chao, Mark E. Davis, Jungyeon Hwang, Douglas Lazarus, Thomas Schluep, James Lin, Yun Yen, Roy I. Case, Han Han, Scott Eliasof, Devin T. Wiley, Jonathan E. Zuckerman, Roderic O. Cole
Publikováno v:
Proceedings of the National Academy of Sciences. 110:15127-15132
Nanoparticles are currently being investigated in a number of human clinical trials. As information on how nanoparticles function in humans is difficult to obtain, animal studies that can be correlative to human behavior are needed to provide guidanc
Autor:
Warren Chow, Glen J. Weiss, Mark E. Davis, Jeffrey Longmate, John L. Ryan, Yun Yen, D. Lynn Kalinoski, James A. Neidhart, Edward G. Garmey, Marianna Koczywas, Robert J. Morgan, Jeffrey D. Neidhart, Thomas Schluep, Chung Hang Jonathan Choi, Jamie Oliver, Joseph Chao, Joanna J. Peterkin, Jungyeon Hwang, Timothy W. Synold, Stephen J. Forman, Ramesh K. Ramanathan, Roger J. Melton, Przemyslaw Twardowski, Dawn Bassett, Vincent Chung
Publikováno v:
Investigational New Drugs. 31:986-1000
Patients with advanced solid malignancies were enrolled to an open-label, single-arm, dose-escalation study, in which CRLX101 was administered intravenously over 60 min among two dosing schedules, initially weekly at 6, 12, and 18 mg/m(2) and later b
Publikováno v:
ECS Meeting Abstracts. :779-779
Titanium dioxide (TiO2) is an important metal-oxide semiconductor for photocatalytic applications due to its unique properties, such as photostability, low cost, abundance and nontoxicity. Despite of outstanding functionality, wide band gap of 3.2eV